Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY 4.0Frontiers in Microbiology

Caenorhabditis elegans Slow Killing recapitulates chronic Pseudomonas aeruginosa infection and reveals mediators of host-pathogen interactions

  1. 1Department of BioSciences, Rice University
  2. 2Department of Bioengineering, Rice University

Abstract

Pseudomonas aeruginosa is a leading cause of healthcare-associated infections, especially in immunocompromised patients and individuals with cystic fibrosis (CF). P. aeruginosa commonly causes chronic infections within the respiratory tracts of patients with CF. These infections are marked by a shift from the production of acute virulence factors (secreted toxins) to colonization (biofilm formation) and persistence within the host. To better understand the transcriptomic changes that occur during this shift within the context of host-pathogen interactions, we took advantage of a whole-organism model system. Using an established Caenorhabditis elegans – P. aeruginosa colonization model, we identified genes differentially regulated during establishment of the infection of the C. elegans intestine. By comparing this transcriptomic signature to those from P. aeruginosa from CF sputum samples and an ex vivo porcine lung biofilm model, we demonstrated that Slow Killing partially recapitulates chronic lung infection. Notably, we observed the upregulation of lipid A and exopolysaccharide (Pel, alginate) biosynthetic genes within the nematode host and downregulation of acute virulence pathways including quorum-sensing, phenazine production, toxin secretion, and siderophore-mediated iron uptake. Further characterization of these differentially-regulated genes revealed key bacterial pathways, including quorum-sensing and the PhoPQ regulatory network, that impacted host survival during infection. These results demonstrate that the C. elegans Slow Killing model is a highly accessible tool for studying host-pathogen interactions and benchmark it against clinical samples.

Related

  1. Phenotypic heterogeneity in Pseudomonas aeruginosa virulence revealed through passive exposure in zebrafish (Danio rerio) and nematodes (Caenorhabditis elegans).
    Daniella Azulai, Anielka Espinosa, Maracela Talamantes +2
    Access microbiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Human airway model reveals host-pathogen co-infection dynamics of Staphylococcus aureus and Pseudomonas aeruginosa
    Katrine Madsen, Signe Lolle, Martin Saxtorph Bojer +4
    ISME CommunicationsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  3. Regulatory role and mechanism of sRNA24 targeting pqsH in Pseudomonas aeruginosa infection immunity
    Huanlan Liao, Qianying Liu, Yuyang Liu +4
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  4. D-enantiomeric β-casein 197 disrupts biofilm-associated infection of MDR Pseudomonas aeruginosa and Acinetobacter baumannii through superior LPS binding and host cell protection
    Kaichong Jiang, Wei Wang, Hong Lei +6
    VirulencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  5. Pulmonary megakaryocytes orchestrate host defense via PcrV-induced NF-κB signaling in Pseudomonas aeruginosa infection
    Xiaolong Guo, Qian Dai, Xiping Liao +8
    Cell Communication and Signaling : CCSPeer-reviewedCC BY 4.0Full text1 citedMolecular biology & gene regulationPMCDOAJ
BibTeX
@article{gaskins2026caenorhabditis,
  title = {{Caenorhabditis elegans Slow Killing recapitulates chronic Pseudomonas aeruginosa infection and reveals mediators of host-pathogen interactions}},
  author = {Sadie Gaskins and Liyang Zhang and Donghoon Kang and Qi Xu and Natalia V. Kirienko},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fmicb.2026.1990701},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1990701/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Caenorhabditis elegans Slow Killing recapitulates chronic Pseudomonas aeruginosa infection and reveals mediators of host-pathogen interactions
AU  - Sadie Gaskins
AU  - Liyang Zhang
AU  - Donghoon Kang
AU  - Qi Xu
AU  - Natalia V. Kirienko
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1990701
UR  - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1990701/full
AB  - Pseudomonas aeruginosa is a leading cause of healthcare-associated infections, especially in immunocompromised patients and individuals with cystic fibrosis (CF). P. aeruginosa commonly causes chronic infections within the respiratory tracts of patients with CF. These infections are marked by a shift from the production of acute virulence factors (secreted toxins) to colonization (biofilm formation) and persistence within the host. To better understand the transcriptomic changes that occur during this shift within the context of host-pathogen interactions, we took advantage of a whole-organism model system. Using an established Caenorhabditis elegans – P. aeruginosa colonization model, we identified genes differentially regulated during establishment of the infection of the C. elegans intestine. By comparing this transcriptomic signature to those from P. aeruginosa from CF sputum samples and an ex vivo porcine lung biofilm model, we demonstrated that Slow Killing partially recapitulates chronic lung infection. Notably, we observed the upregulation of lipid A and exopolysaccharide (Pel, alginate) biosynthetic genes within the nematode host and downregulation of acute virulence pathways including quorum-sensing, phenazine production, toxin secretion, and siderophore-mediated iron uptake. Further characterization of these differentially-regulated genes revealed key bacterial pathways, including quorum-sensing and the PhoPQ regulatory network, that impacted host survival during infection. These results demonstrate that the C. elegans Slow Killing model is a highly accessible tool for studying host-pathogen interactions and benchmark it against clinical samples.
SN  - 1664-302X
ER  -